The Center for Tobacco Products (CTP) is part of the Food and Drug Administration.
The CTP is responsible for implementing the Family Smoking Prevention and Tobacco Control Act passed in 2009. The Tobacco Control Act gives the organization “broad authority to regulate the manufacturing, distribution, and marketing of tobacco products.”
The CTP makes decisions on whether new tobacco products and claims can be marketed—including reviewing and evaluating applications and claims before new products are allowed on the market. The CTP says its goals are:
According to a press release from the Office of Special Counsel (OSC), problems in assessing risk of some tobacco products have now been uncovered based on a complaint filed by a whistleblowing federal employee. According to the press release, the CTP has “relaxed its standards of review for certain tobacco products and stifled attempts by its scientists to raise concerns.”
The headline issued by OSC reads: “Unclear Standards for Scientific Review and Stifling of Scientific Dissent Resulted in Flawed FDA Process for Evaluating Potential Harm of Tobacco Products”.
A CTP toxicologist (the whistleblower) reported to OSC that a 2019 memorandum sent to CTP’s scientists revised the process for evaluating potentially harmful ingredients in “substantial...
Jayson Tatum is being raked over the coals on social media and drawing criticism in recent days due to a perceived lack of durability. This narrative is extremely dumb and nowhere close to accurat...